3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
about
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activationAuditory stimuli enhance MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin and locomotor responses.Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in micePrior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in ratsEffects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug usersHuman Ecstasy use is associated with increased cortical excitability: an fMRI study.MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion.The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stressOccipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug usersThe sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature.Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptorsThe nucleus accumbens 5-HTR₄-CART pathway ties anorexia to hyperactivity.Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: effects of pretreatment with 5-HT1A and dopamine D2 antagonists.Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses.Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.
P2860
Q24619949-8C33BEAE-59E6-4BF6-8376-1370AB96B2C1Q28540131-F8500580-AE6F-4E7D-91D1-95E2D3BE7699Q30371569-79797268-E1B3-4D53-AE2C-2535134B06A5Q30946517-782B6597-DCBF-4563-91AC-5579DE5B4AA3Q33586450-C6A4F1A2-9C00-48B4-BD5A-6119740C3426Q33835470-B4B7B66E-3345-4DFB-99B4-86432BC3CDADQ34391195-9CC4889F-FD1D-43FB-B7C8-2887F398DAF4Q34565712-9E80A6C2-FB6F-40F5-ABFF-BCCA71E5862AQ34634128-BDD77DE3-D887-4DC1-8475-A25C3C714372Q34820201-798406D7-FA91-430A-A51A-4F293F8168BBQ35575169-ADFD6058-6F3A-4403-9B04-3FC3F9FCB041Q35590703-6EB7CD1E-6A86-4C6A-BEFE-ED646BC84FC3Q35750662-C2BE9B8D-AD17-4280-AB1F-CEE71B2735CCQ36020541-D383A6FE-E0F6-4A7C-A986-A47FDC4B9420Q36255067-969E5C2E-3C77-4620-90EA-93E3688A658BQ36294620-5AFD0C64-FADE-4219-9664-87C924131A92Q36357993-768232ED-C10C-4E77-B5D9-E42415C8BE95Q36589680-65A21346-DC0C-4D83-AAFA-717E18ADB1E9Q36666580-BCBFFA3F-A5A4-44FC-B0F8-31EECDB5F798Q36800689-F116CC9F-90D4-4D1E-B6FC-44B02013CAF5Q36856179-BAC5E032-03BB-48FC-A54D-A1458CF64BF7Q37011117-3DA3BFBA-3A57-41E4-B552-603EBFA90D88Q42135507-5E68E519-EEB4-4143-B173-5FDB189F9C44
P2860
3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@ast
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@en
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@nl
type
label
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@ast
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@en
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@nl
prefLabel
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@ast
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@en
3,4-Methylenedioxymethamphetam ...... rotonin-dopamine interactions.
@nl
P1476
3,4-Methylenedioxymethamphetam ...... erotonin-dopamine interactions
@en
P2093
Bankson MG
Cunningham KA
P304
P407
P577
2001-06-01T00:00:00Z